help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Panzer, C.
Right arrow Articles by Braverman, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Panzer, C.
Right arrow Articles by Braverman, L.
The Journal of Clinical Endocrinology & Metabolism Vol. 89, No. 5 2142-2144
Copyright © 2004 by The Endocrine Society

Rapid Preoperative Preparation for Severe Hyperthyroid Graves’ Disease

Claudia Panzer, Robert Beazley and Lewis Braverman

Department of Surgery and Section of Endocrinology, Diabetes, and Nutrition, Boston Medical Center, Boston, Massachusetts 02118

Address all correspondence and requests for reprints to: Dr. Lewis Braverman, Department of Endocrinology, Diabetes, and Metabolism, 88 East Newton Street, Boston, Massachusetts 02118. E-mail: lewis.braverman{at}bmc.org.

Thyroidectomy (TX) is no longer the preferred choice for the therapy of hyperthyroid Graves’ disease but is an alternative in patients who are noncompliant with or have reactions to antithyroid drugs, have moderate to severe ophthalmopathy, have large goiters, or who refuse 131I therapy and/or long-term antithyroid drug therapy. Seventeen clinically and biochemically severely thyrotoxic patients (16 female, mean age of 35 yr), all but one with large goiters, underwent TX after rapid preparation. The potent inhibitors of the deiodination of T4 to T3, iopanoic acid (IOP) (500 mg twice a day) and dexamethasone (DEX) (1 mg twice a day), were given with propylthiouracil or methimazole, when possible, and ß-blockers. Thyroid function tests were obtained before treatment and at TX. All patients were thyrotoxic (mean ± SE: T4, 21.6 ± 1.2 µg/dl; free T4 index (FTI), 10.3 ± 0.8; total T3, 510 ± 48 ng/dl). IOP and DEX rapidly lowered T3 values (P < 0.0001; total T3, 147 ± 13 ng/dl) with a smaller but significant (P < 0.05) decrease in T4/FTI (T4, 17.9 ± 1.3 µg/dl; FTI, 7.9 ± 0.6). All patients were clinically euthyroid before surgery. None developed hypoparathyroidism, laryngeal nerve damage, or worsening of ophthalmopathy after surgery. The restoration of hyperthyroid Graves’ disease to euthyroidism is rapidly accomplished with IOP and DEX, ß-blockers, and, when possible, antithyroid drugs. This is especially relevant in noncompliant patients with large goiters.

Abbreviations: DEX, Dexamethasone; FTI, free T4 index; IOP, iopanoic acid; IRCA, iodinated radiographic contrast agent; MMI, methimazole; PTU, propylthiouracil; TX, thyroidectomy.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
C. S. Bal, A. Kumar, and P. Chandra
Effect of Iopanoic Acid on Radioiodine Therapy of Hyperthyroidism: Long-Term Outcome of a Randomized Controlled Trial
J. Clin. Endocrinol. Metab., December 1, 2005; 90(12): 6536 - 6540.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
C. Panzer and L. Braverman
Authors' Response: Rapid Preoperative Preparation for Severe Hyperthyroid Graves' Disease
J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5867 - 5867.
[Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
Y. Liel
Rapid Preoperative Preparation for Severe Hyperthyroid Graves' Disease
J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5866 - 5867.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2004 by The Endocrine Society